Not medical advice: Educational content only. Author is not a doctor. Consult a licensed healthcare professional.
Common questions about this educational resource
Reminder: This website provides educational information only. Not medical advice. Always consult qualified healthcare professionals.
No. This website provides educational information only. It summarizes available research and real-world experiences, but it is not medical advice, diagnosis, or treatment guidance.
No. No treatment instructions or protocols are provided. Any health decisions should be made with a qualified healthcare provider.
Peer-reviewed research, published case reports, and information from reputable public institutions. See our Sources page for references.
No. Mark Becker is not a licensed physician, nurse, or healthcare provider. He is an independent researcher sharing educational information based on personal research after losing loved ones to cancer.
No. Always consult a licensed healthcare professional for diagnosis and treatment decisions. This site is for educational research purposes only.
Yes, it may. If you click an affiliate link and make a purchase, the site may earn a commission at no additional cost to you. This helps support the maintenance of this educational resource.
Fenbendazole has shown anticancer activity in laboratory and animal studies, and there are published human case reports. However, there are no large clinical trials proving it cures cancer in humans, and it is not approved as a cancer treatment by regulators.
No. Ivermectin is approved as an antiparasitic drug. While preclinical research suggests potential anticancer effects and some early oncology trials have begun, ivermectin is not approved as a cancer therapy.
Preclinical research includes laboratory (in vitro) and animal studies. Clinical research involves human trials. Over 90% of compounds that show promise in preclinical studies never reach clinical approval.